To corroborate this finding, we used the R2 Genomics analysis and visualization platform and evaluated the mRNA levels of praja2 in kidney tumors (EXPO project, n = 261) and normal counterpart tissues (Tsunoda’s project, n = 24). The gene discussed is PJA2; the disease is kidney neoplasm.